Use of Cabozantinib to Treat MET-amplified Pediatric Colorectal Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002482
Abstract: Pediatric colorectal cancer (CRC) is extremely rare, with little information about genetic profiles compared with adult CRC. Here, a 13-year-old male with advanced CRC underwent cancer gene panel testing, which detected 4 genetic abnormalities (MET… read more here.
Keywords: pediatric colorectal; use cabozantinib; colorectal cancer; cabozantinib treat ... See more keywords